Digital twin technology for stroke and related conditions
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a digital twin system to help prevent a second stroke or brain bleed in people with stroke, Moyamoya disease, or cerebral amyloid angiopathy. The system uses your medical data to create a virtual copy of you, which doctors can use to plan your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a stroke, or have been diagnosed with Moyamoya disease or cerebral amyloid angiopathy.
- Your thinking and memory test (MOCA) score is 23 or higher.
- You are able to do daily activities on your own (modified Rankin Scale score of 2 or less).
- You are a new patient at the Besta Institute in Milan.
- You can have an MRI brain scan.
- You are able to sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new artificial intelligence tool designed to help doctors better understand and predict how well stroke patients will recover. You would be recorded performing simple tasks so the AI can learn to recognize patterns in stroke recovery.
This study uses digital twin technology to predict how well people will recover after a stroke. It looks at your walking ability and other factors to create a personalized recovery plan.
This trial tests whether a special AI software can help doctors speed up the process of referring patients with acute stroke for a procedure that removes a blood clot (thrombectomy). If you have stroke symptoms and a recent CT scan, the AI may help identify if you could benefit from this treatment.
This trial tests an AI system that creates a personalized digital model of your recovery after a stroke. The system aims to help guide your rehabilitation by continuously assessing your progress.
This study tests a new artificial intelligence system that automatically scores stroke recovery progress. Researchers will compare the AI scoring with standard doctor assessments to see if it's accurate and helpful for tracking how well stroke patients improve.
This study at Vanderbilt tests whether certain biomarkers (signs in your blood or brain scans) can help tailor care for people with Moyamoya, a condition where blood flow to the brain is reduced. Participants will have brain scans and complete study procedures before and after surgery to improve blood flow.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.